NCT06226168 Effects of Normobaric Hypoxia Exercise Program on Bone Turnover Markers and Metabolism in Premenopausal Women
| NCT ID | NCT06226168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University School of Physical Education, Krakow, Poland |
| Condition | Hypoxia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-05-07 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-05-07 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The impact of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women falls within the realm of physical culture for an active and healthy society. Within this context, the implementation of a project is supported aiming to: 1. Monitor, support, and promote physical development, fitness, and physical activity in society, by assessing the effects of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women. 2. Develop and implement innovative methods, forms, and means of physical activation and training for individuals of various ages, by formulating general assumptions of an endurance-strength training concept under normobaric hypoxia conditions, concerning changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women. 3. Prevent injuries in physical education and sports, by designing a useful training program for osteoporosis prevention as well as for managing carbohydrate and lipid metabolism disorders in premenopausal women.
Eligibility Criteria
Inclusion Criteria: * No significant cardiovascular, respiratory system diseases and musculoskeletal system, * No contraindications to physical activity. ECG, baseline urinalysis, morphology are required. * T-score within normal limits (+1.0 to -1.0). * Informed consent of the patient to participate in the study. Exclusion Criteria: * Use of hormone replacement therapy (HRT). * Use of substances (cigarettes, alcohol). * Any training (including hypoxia training or exposure) performed in the 6 months prior to the beginning of the intervention * Any other factors determined by the study investigators as unsuitable for participation.
Contact & Investigator
Małgorzata Bagińska, MSc
PRINCIPAL INVESTIGATOR
Student of Doctoral studies, University of Physical Education in Kraków, Poland
Frequently Asked Questions
Who can join the NCT06226168 clinical trial?
This trial is open to female participants only, aged 50 Years or older, up to 59 Years, studying Hypoxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06226168 currently recruiting?
Yes, NCT06226168 is actively recruiting participants. Contact the research team at anna.radon@awf.krakow.pl for enrollment information.
Where is the NCT06226168 trial being conducted?
This trial is being conducted at Krakow, Poland, Krakow, Poland.
Who is sponsoring the NCT06226168 clinical trial?
NCT06226168 is sponsored by University School of Physical Education, Krakow, Poland. The principal investigator is Małgorzata Bagińska, MSc at Student of Doctoral studies, University of Physical Education in Kraków, Poland. The trial plans to enroll 60 participants.